Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jan 27, 2025; 17(1): 97148
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.97148
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.97148
Table 1 Basic information on the gene expression omnibus dataset included in the study
GEO | Group | n | Stage | Tissue | Gene number |
GSE21510 | CN | 12 | 0-2 | Normal | 715 |
CRC | 8 | 1-2b | Cancer | ||
GSE25071 | CN | 3 | 0 | Colon | 788 |
CRC | 7 | I-II | Primary tumor | ||
GSE32323 | CN | 9 | 1-2 | Normal | 446 |
CRC | 9 | 1-2b | Cancer |
Table 2 Sequence information of the primers for quantitative real time-polymerase chain reaction
Gene | Forward primer | Reverse primer |
Human AURKA | 5’-TGGGTGGTCAGTACATGCTC-3’ | 5’-TGCATCCGACCTTCAATCATTTC-3’ |
Human TPX2 | 5’-ACTTCCGCACAGATGAGCG-3’ | 5’-GGATGCTTTCGTAGTTCAGATGT-3’ |
Human β-actin | 5’-GATGACCCAGATCATGTTTGAG-3’ | 5’-TAATGTCACGCACGATTTCC-3’ |
Table 3 Antibody information
Antibody | Manufacturer | No. | Dilution ratio |
AURKA antibody | Affinity | BF0123 | 1:2000 |
TPX2 antibody | Abcam | ab264124 | 1:5000 |
Cyclin B1 antibody | Affinity | AF6168 | 1:2000 |
CDK1 antibody | Abcam | ab133327 | 1:15000 |
CDK2 antibody | Affinity | AF6237 | 1:2000 |
Bax antibody | Abcam | ab182733 | 1:2000 |
Bcl-2 antibody | Affinity | AF6139 | 1:2000 |
Caspase-3 antibody | Proteintech | 19677-1-AP | 1:10000 |
p53 antibody | Affinity | AF0879 | 1:2000 |
N-cadherin antibody | Affinity | AF4039 | 1:2000 |
E-cadherin antibody | Proteintech | 20874-1-AP | 1:5000 |
Vimentin antibody | Zenbio | R22775 | 1:1000 |
p-AURKA antibody | Affinity | AF3011 | 1:2000 |
β-actin antibody | Proteintech | 81115-1-RR | 1:20000 |
Anti-rabbit IgG, HRP-linked antibody | CST | 7074 | 1:10000 |
Table 4 Potential target proteins and their degrees in the relative overexpressed gene set analyzed by Cytoscape
No. | Node | Degrees |
1 | CCNB1 | 14 |
2 | CDK1 | 14 |
3 | CDKN3 | 13 |
4 | UBE2C | 13 |
5 | ANLN | 12 |
6 | AURKA | 12 |
7 | CENPA | 12 |
8 | CKS2 | 12 |
9 | TPX2 | 12 |
10 | CENPN | 11 |
11 | TRIP13 | 11 |
12 | CKAP2 | 10 |
13 | CXCL10 | 10 |
Table 5 The search tool for the retrieval of interacting genes analysis results of protein-protein interaction forces (TOP 7, score = 0.999)
Node 1 | Node 2 | Co-expression | Experimentally determined interaction | Database annotated | Combined score |
CCNB1 | CDK1 | 0.895 | 0.999 | 0.9 | 0.999 |
AURKA | TPX2 | 0.846 | 0.988 | 0.9 | 0.999 |
CXCL10 | CXCL11 | 0.824 | 0.994 | 0.9 | 0.999 |
CDK1 | CKS2 | 0.689 | 0.992 | 0 | 0.999 |
CCNB1 | CKS2 | 0.688 | 0.978 | 0 | 0.999 |
CENPA | CENPN | 0.407 | 0.955 | 0.5 | 0.999 |
CXCL11 | CXCL2 | 0.107 | 0.994 | 0.5 | 0.999 |
- Citation: Sheng GX, Zhang YJ, Shang T. Synergistic inhibition of colorectal cancer progression by silencing Aurora A and the targeting protein for Xklp2. World J Gastrointest Surg 2025; 17(1): 97148
- URL: https://www.wjgnet.com/1948-9366/full/v17/i1/97148.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i1.97148